Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
100%
Patient
100%
Drug Resistance
50%
Resistance Mutation
50%
Human Immunodeficiency Virus Type 1 Subtype B
33%
Inpatient
33%
Stavudine
16%
Combination Therapy
16%
RNA
16%
Proteinase
16%
Reverse-Transcriptase Inhibitor
16%
Epidemic
16%
Tenofovir
16%
RNA Directed DNA Polymerase
16%
Sequence Analysis
16%
Gene
16%
Efavirenz Plus Lamivudine Plus Zidovudine
16%
Lamivudine Plus Nevirapine Plus Zidovudine
16%
Therapeutic Procedure
16%
Plasma
16%
INIS
patients
100%
therapy
100%
mutations
100%
hiv
100%
nigeria
100%
drugs
30%
rna
10%
genes
10%
failures
10%
plasma
10%
sequence analysis
10%
nucleosides
10%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Drug Resistance
50%
Human Immunodeficiency Virus Type 1 Subtype B
33%
RNA
16%
RNA Directed DNA Polymerase
16%
Proteinase
16%
Stavudine
16%
RNA Directed DNA Polymerase Inhibitor
16%
Tenofovir
16%
Epidemic
16%
Lamivudine Plus Nevirapine Plus Zidovudine
16%
Efavirenz Plus Lamivudine Plus Zidovudine
16%
Immunology and Microbiology
Mutation
100%
Human Immunodeficiency Virus
100%
Drug Resistance
30%
Reverse Transcriptase
20%
Human Immunodeficiency Virus Type 1 Subtype B
20%
Blood Plasma
10%
Sequence Analysis
10%
Tenofovir
10%
Gene
10%
Neuroscience
HIV
100%
Drug Resistance
37%
RNA
12%
Proteinase
12%
Tenofovir
12%
Reverse Transcriptase Inhibitors
12%
Stavudine
12%
Nevirapine
12%
Gene
12%
Efavirenz
12%
Nucleoside
12%
Reverse Transcriptase
12%
Lamivudine/Zidovudine
12%
Antiretroviral Drugs
12%